X0708 D LIVE 0001372514 EYEGATE PHARMACEUTICALS INC 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA MASSACHUSETTS 02452 781-788-9043 DELAWARE None None Corporation true Stephen From 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer Director President and Chief Executive Officer Sarah Romano 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer Chief Financial Officer Bernard Malfroy-Camine 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Paul Chaney 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Steven Boyd 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Morton Goldberg 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Praveen Tyle 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Thomas Hancock 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Keith Maher 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Pharmaceuticals Decline to Disclose 06b false 2020-12-18 false true true This Form D relates to the issuance of shares of common stock and Series D Convertible Preferred Stock as merger consideration to the former stockholders of Panotpes Pharma G.m.b.H and its financial advisor. 0 Indefinite 3203083 Indefinite 884,222 shares of common stock and 45.8923 shares of Series D Convertible Preferred Stock were issued on 12/18/2020. Additional shares may include up to $1.5 million in value of holdback shares and up to $9.5 million in value of potential earnout shares. false 15 0 0 0 false EYEGATE PHARMACEUTICALS INC /s/ Sarah Romano Sarah Romano Chief Financial Officer 2020-12-31